Inhalation Sciences Sweden AB (publ) (XSAT:ISAB)
0.1805
-0.0045 (-2.43%)
At close: Aug 6, 2026
XSAT:ISAB Market Cap
XSAT:ISAB has a market cap or net worth of 9.24 million as of August 7, 2026. Its market cap has decreased by -85.96% in one year.
Market Cap
9.24M
Enterprise Value
5.85M
Revenue
6.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.18
ChartMarket Cap Chart
Since September 28, 2017, XSAT:ISAB's market cap has decreased from 79.73M to 9.24M, a decrease of -88.41%. That is a compound annual growth rate of -21.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 9.24M | -84.92% |
| Dec 29, 2023 | 61.28M | 10.84% |
| Dec 30, 2022 | 55.29M | -52.35% |
| Dec 30, 2021 | 116.03M | 16.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hunter Capital RTO 2 AB | 17.03M |
| Biofrigas Sweden AB | 15.79M |
| Tessin Nordic Holding AB | 15.52M |
| Proport Invest AB | 15.00M |
| Exalt AB | 14.92M |
| Monivent AB | 14.82M |
| Risk Intelligence | 13.71M |
| C100 AB | 13.44M |